Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2022 · 10-Q
Revenue$67.10M$67.10M−11.1% vs Q2 2021 Net Income$5.77M$5.77M−31.4% vs Q2 2021 EPS Diluted$0.31$0.31−26.2% vs Q2 2021 Gross Profit$19,174,000−16.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,497,000−94.3% Free Cash Flowderived$1,002,000−96.0% Margins · derivedGross margin28.6%−1.9 pt vs Q2 2021
Operating margin12.1%−1.8 pt vs Q2 2021
Net margin8.6%−2.5 pt vs Q2 2021
ended Sep 30, 2021 · filed Nov 2, 2021 · 33 d after period end